Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 276

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Open access
Panigrahy, Dipak, Singer, Samuel, Shen, Lucy Q., Butterfield, Catherine E., Freedman, Deborah A., Chen, Emy J., Moses, Marsha A., Kilroy, Susan, Duensing, Stefan, Fletcher, Christopher, Fletcher, Jonathan A., Hlatky, Lynn, Hahnfeldt, Philip, Folkman, Judah, Kaipainen, Arja·2002·Journal of Clinical Investigation

Abstract

Several drugs approved for a variety of indications have been shown to exhibit antiangiogenic effects.Our study focuses on the PPARγ ligand rosiglitazone, a compound widely used in the treatment of type 2 diabetes.We demonstrate, for the first time to our knowledge, that PPARγ is highly expressed in tumor endothelium and is activated by rosiglitazone in cultured endothelial cells.Furthermore, we show that rosiglitazone suppresses primary tumor growth and metastasis by both direct and indirect antiangiogenic effects.Rosiglitazone inhibits bovine capillary endothelial cell but not tumor cell proliferation at low doses in vitro and decreases VEGF production by tumor cells.In our in vivo studies, rosiglitazone suppresses angiogenesis in the chick chorioallantoic membrane, in the avascular cornea, and in a variety of primary tumors.These results suggest that PPARγ ligands may be useful in treating angiogenic diseases such as cancer by inhibiting angiogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci0215634

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 45

  1. Rosen, 2001, J Biol Chem, 276, 37731, 10.1074/jbc.M106424200 · DOI · Paper page
  2. 10.1016/S1097-2765(00)80209-9 · DOI · Paper page
  3. 10.1016/0092-8674(94)90006-X · DOI · Paper page
  4. 10.1016/S0092-8674(00)81575-5 · DOI · Paper page
  5. 10.1016/S1097-2765(00)80047-7 · DOI · Paper page
  6. 10.1038/2030 · DOI · Paper page
  7. 10.1073/pnas.94.1.237 · DOI · Paper page
  8. 10.1073/pnas.95.15.8806 · DOI · Paper page
  9. Kubota, 1998, Cancer Res, 58, 3344
  10. Nakashiro, 2001, Am J Pathol, 159, 591, 10.1016/S0002-9440(10)61730-0 · DOI
  11. 10.1210/jc.86.5.2170 · doi:10.1210/jc.86.5.2170
  12. Palakurthi, 2001, Cancer Res, 61, 6213
  13. Marx, 1999, Arterioscler Thromb Vasc Biol, 19, 546, 10.1161/01.ATV.19.3.546 · DOI · Paper page
  14. 10.1074/jbc.274.13.9116 · DOI · Paper page
  15. 10.1074/jbc.274.24.17042 · DOI · Paper page
  16. 10.1097/00005344-199806000-00015 · DOI
  17. Murata, 2000, Invest Ophthalmol Vis Sci, 41, 2309
  18. Inoue, 2001, Anticancer Res, 21, 2471
  19. Slaton, 1999, Clin Cancer Res, 5, 2726
  20. Masferrer, 2000, Cancer Res, 60, 1306
  21. 10.1016/0092-8674(94)90200-3 · DOI · Paper page
  22. 10.1093/jnci/84.12.951 · DOI · Paper page
  23. Braunhut, 1994, J Biol Chem, 269, 13472, 10.1016/S0021-9258(17)36856-4 · DOI
  24. 10.1126/science.1694043 · DOI · Paper page
  25. 10.1074/jbc.M001297200 · DOI · Paper page
  26. 10.1073/pnas.96.6.2645 · DOI · Paper page
  27. Browder, 2000, Cancer Res, 60, 1878
  28. 10.1146/annurev.med.53.082901.104018 · DOI · Paper page
  29. 10.2174/1389201003379040 · DOI
  30. 10.1016/S0093-7754(01)90021-1 · DOI · Paper page
  31. Hlatky, 2002, J Natl Cancer Inst, 94, 883, 10.1093/jnci/94.12.883 · DOI · Paper page
  32. Pihan, 1998, Cancer Res, 58, 3974
  33. 10.1006/bbrc.1996.1044 · DOI · Paper page
  34. 10.1007/s002280050592 · DOI
  35. 10.1126/science.281.5383.1683 · DOI · Paper page
  36. 10.1038/72303 · DOI · Paper page
  37. 10.1038/71517 · DOI · Paper page
  38. Morikawa, 2002, Am J Pathol, 160, 985, 10.1016/S0002-9440(10)64920-6 · DOI · Paper page
  39. Sunderkotter, 1994, J Leukoc Biol, 55, 410, 10.1002/jlb.55.3.410 · DOI · Paper page
  40. Pasceri, 2000, Circulation, 101, 235, 10.1161/01.CIR.101.3.235 · DOI · Paper page
  41. Drixler, 2000, Cancer Res, 60, 1761
  42. 10.1172/JCI9023 · doi:10.1172/jci9023
  43. 10.2310/6650.2001.33786 · DOI · Paper page
  44. 10.1016/0092-8674(91)90642-C · DOI · Paper page
  45. Fahmi, 2002, J Rheumatol, 29, 3

Cited by

See all 276

Metadata

Authors
Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C. E., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S., Duensing, S., Fletcher, C., Fletcher, J. A., Hlatky, L., Hahnfeldt, P., Folkman, J., & Kaipainen, A.
Venue
Journal of Clinical Investigation
Published
2002-10-01
Volume
110
Issue
7
Pages
923-932
ISSN
0021-9738 (ISSN-L)
OpenAlex
W4240908764
Cited by
276
References
2
FWCI
5.40
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. https://app.cochat.ai/papers/10.1172/jci0215634
The paper
Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C. E., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S., Duensing, S., Fletcher, C., Fletcher, J. A., Hlatky, L., Hahnfeldt, P., Folkman, J., & Kaipainen, A. (2002). PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. Journal of Clinical Investigation. https://doi.org/10.1172/jci0215634

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.